使用尿素来预测心肌梗塞后心力衰竭风险
Ganchimeg Ulziisaikhan1,2, Mungun-Ulzii Khurelbaatar1, Chingerel Khorloo2
1National Cardiovascular Center, The Third State Central Hospital.
Cardiovascular endocrinology & metabolism
|July 17, 2025
概括
在排泄前测量的N-终端亲B型尿素 (NT-proBNP) 可以预测急性心肌梗塞 (AMI) 后的心力衰竭 (HF). 这种生物标志物有助于早期风险分层,以更好地管理AMI幸存者的患者.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 临床医学 临床医学
背景情况:
- 缺血性心脏病,特别是急性心肌梗塞 (AMI),是蒙古慢性心力衰竭 (HF) 的主要原因.
- 早期识别HF风险后AMI对于有效的患者管理至关重要.
- 这项研究研究了N-终端亲B型尿素 (NT-proBNP) 用于AMI后无症状左心室 (LV) 功能障碍的早期检测和预后.
研究的目的:
- 评估NT-proBNP作为AMI后无症状左心室功能障碍的早期预测因素.
- 评估NT-proBNP水平的预后价值,以确定患有De-novo心力衰竭风险的患者.
- 建立NT-proBNP作为一种用于AMI患者风险分层的工具.
主要方法:
- 一项前性研究,包括120名没有HF症状的AMI患者.
- 在基线收集的临床和心声回声数据;在入院和出院时测量NT-proBNP.
- 根据NT-proBNP水平分为四分之一的患者;主要终点是6个月后的de-novo HF.
主要成果:
- 较高的NT-proBNP水平与高的GRACE分数和糖尿病相关.
- 摄入NT-proBNP与延迟呈现相关;排出NT-proBNP与减少LV全球纵向菌株相关.
- 排放的NT-proBNP水平显著预测了6个月的HF发展,其值为1410 pg/ml.
结论:
- 在出院前测量NT-proBNP可以改善AMI患者的风险分层.
- 将NT-proBNP整合到常规临床评估中可以改善患者管理.
- NT-proBNP作为一个有价值的预后生物标志物,用于HF在AMI后的发展.
相关概念视频
01:29Heart Failure II: Pathophysiology
46
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
46
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
01:22Heart Failure Drugs: Diuretics
496
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
496
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
218
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
218
01:30Heart Failure V: Medical Management
27
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
27
01:30Heart Failure VII: Nursing Interventions
142
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
142